Imaging Staging and Response Prediction in Metastatic Hormono-Sensitive Prostate Cancer Patients Receiving Enzalutamide
Clinical trial NCT02815033 · COMPLETED
Trial details
- NCT number
- NCT02815033
- Sponsor
- The European Uro-Oncology Group
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-01
- Primary completion
- 2020-06-01
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.